These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1653137)

  • 1. Sumatriptan--an oral dose-defining study. The Oral Sumatriptan Dose-Defining Study Group.
    Eur Neurol; 1991; 31(5):300-5. PubMed ID: 1653137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral sumatriptan for the long-term treatment of migraine: clinical findings.
    Rederich G; Rapoport A; Cutler N; Hazelrigg R; Jamerson B
    Neurology; 1995 Aug; 45(8 Suppl 7):S15-20. PubMed ID: 7644080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study.
    Sargent J; Kirchner JR; Davis R; Kirkhart B
    Neurology; 1995 Aug; 45(8 Suppl 7):S10-4. PubMed ID: 7644079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. The Sumatriptan Auto-Injector Study Group.
    Eur Neurol; 1991; 31(5):323-31. PubMed ID: 1653140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group.
    Eur Neurol; 1991; 31(5):306-13. PubMed ID: 1653138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions with triptans : which are clinically significant?
    Rolan PE
    CNS Drugs; 2012 Nov; 26(11):949-57. PubMed ID: 23018546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sumatriptan (oral route of administration) for acute migraine attacks in adults.
    Derry CJ; Derry S; Moore RA
    Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD008615. PubMed ID: 22336849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment.
    Tfelt-Hansen P
    J Headache Pain; 2011 Jun; 12(3):275-80. PubMed ID: 21350792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What can be learned from the history of recurrence in migraine? A comment.
    Tfelt-Hansen P
    J Headache Pain; 2009 Oct; 10(5):311-5. PubMed ID: 19705060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Not Available].
    Grotemeyer KH
    Schmerz; 1992 Mar; 6(1):82-91. PubMed ID: 18415598
    [No Abstract]   [Full Text] [Related]  

  • 11. Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients.
    Ferrari A; Pinetti D; Bertolini A; Coccia C; Sternieri E
    Eur J Clin Pharmacol; 2008 May; 64(5):489-95. PubMed ID: 18180912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a comment.
    Tfelt-Hansen P
    J Headache Pain; 2007 Oct; 8(5):273-6. PubMed ID: 17955173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The triptan formulations : how to match patients and products.
    Rapoport AM; Tepper SJ; Bigal ME; Sheftell FD
    CNS Drugs; 2003; 17(6):431-47. PubMed ID: 12697002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of childhood headaches.
    Gupta A; Rothner AD
    Curr Neurol Neurosci Rep; 2001 Mar; 1(2):144-54. PubMed ID: 11898510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review.
    Jhee SS; Shiovitz T; Crawford AW; Cutler NR
    Clin Pharmacokinet; 2001; 40(3):189-205. PubMed ID: 11327198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
    Tfelt-Hansen P; De Vries P; Saxena PR
    Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of oral sumatriptan compared with oral caffeine/ergotamine for migraine.
    Evans KW; Boan JA; Evans JL; Shuaib A
    Pharmacoeconomics; 1997 Nov; 12(5):565-77. PubMed ID: 10174323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multinational investigation of the impact of subcutaneous sumatriptan. II: Health-related quality of life.
    Dahlöf C; Bouchard J; Cortelli P; Heywood J; Jansen JP; Pham S; Hirsch J; Adams J; Miller DW
    Pharmacoeconomics; 1997; 11 Suppl 1():24-34. PubMed ID: 10168040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical guide to the management and prevention of migraine.
    Diener HC; Kaube H; Limmroth V
    Drugs; 1998 Nov; 56(5):811-24. PubMed ID: 9829155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the treatment of primary headaches. Part I: Migraine.
    Leone M; Grazzi L; D'Amico D; Moschiano F; Bussone G
    Ital J Neurol Sci; 1995 Dec; 16(9):577-86. PubMed ID: 8838783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.